Method for enhancing N-acetylglucosamine production through glcK knockout of Bacillus subtilis

US9914949B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9914949-B2
Application numberUS-201514934166-A
CountryUS
Kind codeB2
Filing dateNov 6, 2015
Priority dateJul 7, 2015
Publication dateMar 13, 2018
Grant dateMar 13, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a method for enhancing N-acetylglucosamine production by usage of a recombinant Bacillus subtilis with a glcK knockout. This invention enhanced the production of GlcNAc by knocking out the glcK gene which encodes a glucokinase, thus eliminating the GlcNAc phosphorylation to GlcNAc-6-P. The specific growth rate and content of GlcNAc in the supernatant of the recombinant Bacillus subtilis with the glcK knockout were 0.15 h −1 and 3.0 g/L, respectively, which were 2.32 times and 2.14 times of those of the control strain without glcK knockout. The recombinant Bacillus subtilis of the present invention would be potentially useful for industrial production of GlcNAc.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant Bacillus subtilis with increased GlcNAc production as compared to the parent strain BSGN6-P xylA -glmS-P 43 -GNA1, wherein said recombinant Bacillus subtilis is constructed by knocking out a glcK gene of the strain BSGN6-P xylA -glmS-P 43 -GNA1; wherein said glcK gene encodes a glucokinase; and wherein said BSGN6-P xylA -glmS-P 43 -GNA1 is constructed from Bacillus subtilis 168 Δ nagP Δ gamP Δ gamA Δ nagA Δ nagB Δ ldh Δ pta::lox72, and the expression of glmS and GNA1 of said BSGN6-P xylA -glmS-P 43 -GNA1 are under the control of promoter P xylA and P 43 , respectively. 2. The recombinant Bacillus subtilis of claim 1 , wherein the nucleotide sequence of said glcK gene has a NCBI gene ID: 938206. 3. The recombinant Bacillus subtilis of claim 1 , wherein said glcK gene is knocked out by the following steps: a) constructing a knockout cassette of said glcK gene containing a spectinomycin resistance gene spc; and b) replacing said glcK gene of BSGN6-P xylA -glmS-P 43 -GNA1 with said spc gene by transforming said knockout cassette into said BSGN6-P xylA -glmS-P 43 -GNA1. 4. A method for production of increased GlcNAc, comprising producing increased GlcNAc by using the recombinant Bacillus subtilis of claim 1 , wherein said recombinant Bacillus subtilis is cultured in a synthetic medium to produce increased GlcNAc; and wherein said synthetic medium contains 20 g/L glucose, 6-8 g/L Na 2 HPO 4 , 1-1.5 g/L KH 2 PO 4 , 2-2.25 g/L (NH 4 ) 2 SO 4 , 0.2-0.3 g/L MgSO 4 , 0.5-1.0 g/L FeSO 4 •7H 2 O, 0.05-0.01 g/L thymine and 0.01 g/L tryptophan. 5. The method of claim 4 , wherein said syntehtic medium contains 20 g/L glucose, 7.1 g/L Na 2 HPO 4 , 1.35 g/L KH 2 PO 4 , 2 g/L (NH 4 ) 2 SO 4 , 0.25 g/L MgSO 4 , 1.0 g/L FeSO 4 •7H 2 O, 0.01 g/L MnSO 4 •4H 2 O, 0.01 g/L thymine and 0.01 g/L tryptophan. 6. The method of claim 4 , wherein said method for producing said increased GlcNAc comprises transferring activated seeds of said recombinant Bacillus subtilis into said synthetic medium with an inoculum amount of 5%-10% and adding xylose as an inducer; and cultivating for 28-30 hours at 35-37° C. and 200-220 rpm. 7. The method of claim 6 , wherein said xylose is added to said synthetic medium to a final concentration of 5 g/L.

Assignees

Inventors

Classifications

  • C12P19/26Primary

    Preparation of nitrogen-containing carbohydrates · CPC title

  • for Bacillus · CPC title

  • Bacillus subtilis {; Hay bacillus; Grass bacillus} · CPC title

  • Bacterial isolates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9914949B2 cover?
The present invention provides a method for enhancing N-acetylglucosamine production by usage of a recombinant Bacillus subtilis with a glcK knockout. This invention enhanced the production of GlcNAc by knocking out the glcK gene which encodes a glucokinase, thus eliminating the GlcNAc phosphorylation to GlcNAc-6-P. The specific growth rate and content of GlcNAc in the supernatant of the reco…
Who is the assignee on this patent?
Liu Long, Chen Jian, Du Guocheng, and 5 more
What technology area does this patent fall under?
Primary CPC classification C12P19/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).